Harvard Bioscience, Inc.  

(Public, NASDAQ:HBIO)   Watch this stock  
Find more results for physiological
2.60
-0.10 (-3.70%)
Aug 26 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 2.58 - 2.72
52 week 2.41 - 4.70
Open 2.69
Vol / Avg. 90,030.00/98,744.00
Mkt cap 85.91M
P/E     -
Div/yield     -
EPS -0.57
Shares 34.31M
Beta 1.08
Inst. own 67%
Oct 27, 2016
Q3 2016 Harvard Bioscience Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Jul 28, 2016
Q2 2016 Harvard Bioscience Inc Earnings Release
Jul 28, 2016
Q2 2016 Harvard Bioscience Inc Earnings Call - Webcast
Jun 24, 2016
Harvard Bioscience Inc Annual Shareholders Meeting
Jun 2, 2016
Harvard Bioscience Inc at Benchmark Company LLC One-on-One Conference
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '16) 2015
Net profit margin -2.73% -17.52%
Operating margin -3.21% -2.68%
EBITD margin - 3.35%
Return on average assets -2.47% -14.88%
Return on average equity -3.69% -22.00%
Employees 437 -
CDP Score - -

Address

84 OCTOBER HILL RD
HOLLISTON, MA 01746
United States - Map
+1-508-8938999 (Phone)
+1-508-4295732 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Harvard Bioscience, Inc. is a developer, manufacturer and marketer of a range of scientific instruments, systems and lab consumables used for basic research, drug discovery, clinical and environmental testing. The Company's products are sold to thousands of researchers in over 100 countries through its global sales organization, Websites, catalogs and through distributors. The Company's product range is organized into three commercial product families: Cell and Animal Physiology (CAP), Lab Products and Services (LPS), and Molecular Separation and Analysis (MSA). The Company sells these products under brand names, including Harvard Apparatus, KD Scientific, Denville Scientific, AHN, Hoefer, Biochrom, BTX, Warner Instruments, MCS, HEKA, Hugo Sachs Elektronik, Panlab, Coulbourn Instruments, TBSI and CMA Microdialysis. The Company's products consist of instruments, consumables and systems that are made up of various individual products.

Officers and directors

Earl R. Lewis Independent Chairman of the Board
Age: 72
Bio & Compensation  - Reuters
Jeffrey A Duchemin President, Chief Executive Officer, Director
Age: 49
Bio & Compensation  - Reuters
Robert E Gagnon Chief Financial Officer
Age: 40
Bio & Compensation  - Reuters
Yong Sun Vice President - Strategic Marketing and Business Development
Age: 51
Bio & Compensation  - Reuters
David M. Green Director
Age: 50
Bio & Compensation  - Reuters
James W. Green Director
Age: 57
Bio & Compensation  - Reuters
Neal J. Harte Independent Director
Age: 71
Bio & Compensation  - Reuters
John F. Kennedy Independent Director
Age: 66
Bio & Compensation  - Reuters
Bertrand Loy Independent Director
Age: 50
Bio & Compensation  - Reuters